SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 231 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $36 | -99.9% | 40,255 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $63,000 | -22.2% | 40,255 | 0.0% | 0.01% | -25.0% |
Q2 2022 | $81,000 | -13.8% | 40,255 | 0.0% | 0.01% | +14.3% |
Q1 2022 | $94,000 | -46.3% | 40,255 | +7.2% | 0.01% | -46.2% |
Q4 2021 | $175,000 | -22.2% | 37,555 | +27.2% | 0.01% | -31.6% |
Q3 2021 | $225,000 | -8.5% | 29,535 | +16.1% | 0.02% | -9.5% |
Q2 2021 | $246,000 | +17.1% | 25,435 | 0.0% | 0.02% | 0.0% |
Q1 2021 | $210,000 | +20.7% | 25,435 | 0.0% | 0.02% | +16.7% |
Q4 2020 | $174,000 | -38.7% | 25,435 | 0.0% | 0.02% | -53.8% |
Q3 2020 | $284,000 | +59.6% | 25,435 | -10.0% | 0.04% | +50.0% |
Q2 2020 | $178,000 | +242.3% | 28,275 | +1.0% | 0.03% | +160.0% |
Q1 2020 | $52,000 | -33.3% | 28,000 | +21.7% | 0.01% | -9.1% |
Q4 2019 | $78,000 | +100.0% | 23,000 | +27.8% | 0.01% | +83.3% |
Q3 2019 | $39,000 | -18.8% | 18,000 | 0.0% | 0.01% | -25.0% |
Q2 2019 | $48,000 | -99.7% | 18,000 | +20830.2% | 0.01% | -92.5% |
Q1 2019 | $18,000,000 | +81718.2% | 86 | -97.1% | 0.11% | +3433.3% |
Q2 2018 | $22,000 | – | 3,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Oaktree Fund Advisors, LLC | 66,000 | $503,000 | 48.93% |
SABBY MANAGEMENT, LLC | 1,698,107 | $12,957,000 | 1.75% |
EMFO, LLC | 233,008 | $1,778,000 | 1.57% |
swisspartners Ltd. | 110,000 | $839,000 | 0.65% |
HERITAGE WEALTH MANAGEMENT, LLC | 150,000 | $1,145,000 | 0.41% |
Donald L. Hagan, LLC | 42,929 | $328,000 | 0.19% |
COLLECTIVE FAMILY OFFICE LLC | 44,203 | $337,000 | 0.14% |
Spectrum Wealth Advisory Group, LLC | 18,093 | $138,000 | 0.14% |
NEXPOINT ASSET MANAGEMENT, L.P. | 100,000 | $763,000 | 0.13% |
Cormorant Asset Management, LP | 400,000 | $3,052,000 | 0.12% |